Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

East Africa Generic Drug Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The East Africa generic drug market size reached US$ 2.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 3.0 Billion by 2027, exhibiting a growth rate (CAGR) of 6.97% during 2022-2027.

Generic drugs are medications that contain the same active ingredients and have the same therapeutic effect as their branded counterparts. These drugs may differ in packaging but are identical in quality, strength, dosage, performance, and efficiency. As they are cost-efficient, the demand for generic drugs is escalating in the East African region.

The market is primarily driven by rapid urbanization, along with improving infrastructure and healthcare facilities in the East African region. Apart from this, governments of different countries in the region are introducing price control policies and import restrictions to encourage domestic drug manufacturing. This, in turn, is propelling the growth of the generic drugs market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the East Africa generic drug market report, along with forecasts at the regional and country level from 2022-2027. Our report has categorized the market based on segment, therapy area, drug delivery and distribution channel.

Breakup by Segment:

  • Unbranded Generics
  • Branded Generics
     

Breakup by Therapy Area:

  • Central Nervous System
  • Cardiovascular
  • Dermatology
  • Genitourinary/Hormonal
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
     

Breakup by Drug Delivery:

  • Oral
  • Injectables
  • Dermal/Topical
  • Inhalers
     

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospital Pharmacies
     

Breakup by Country:

  • Uganda
  • Burundi
  • Rwanda
  • Kenya
  • Tanzania
  • Others
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Segment, Therapy Area, Drug Delivery, Distribution Channel, Country
Countries Covered Uganda, Burundi, Rwanda, Kenya, Tanzania, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option

Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the East Africa generic drug market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the East Africa generic drug market?
  • What are the key regional markets?
  • What is the breakup of the market based on the segment?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the drug delivery?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the market?
  • What is the structure of the East Africa generic drug market and who are the key players?
  • What is the degree of competition in the market?

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   East Africa Generic Drug Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Segment
    6.1    Unbranded Generics
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Branded Generics
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Therapy Area
    7.1   Central Nervous System
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Cardiovascular
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Dermatology
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Genitourinary/Hormonal
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Respiratory
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Rheumatology
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Diabetes
        7.7.1 Market Trends
        7.7.2 Market Forecast
    7.8    Oncology
        7.8.1 Market Trends
        7.8.2 Market Forecast
    7.9    Others
        7.9.1 Market Trends
        7.9.2 Market Forecast
8   Market Breakup by Drug Delivery
    8.1   Oral
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Injectables
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Dermal/Topical
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Inhalers
        8.4.1 Market Trends
        8.4.2 Market Forecast
9   Market Breakup by Distribution Channel
    9.1    Retail Pharmacies
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Hospital Pharmacies
        9.2.1 Market Trends
        9.2.2 Market Forecast
10  Market Breakup by Country
    10.1    Uganda
        10.1.1 Market Trends
        10.1.2 Market Breakup by Segment
        10.1.3 Market Breakup by Therapy Area
        10.1.4 Market Breakup by Drug Delivery
        10.1.5 Market Breakup by Distribution Channel
        10.1.6 Market Forecast
    10.2    Burundi
        10.2.1 Market Trends
        10.2.2 Market Breakup by Segment
        10.2.3 Market Breakup by Therapy Area
        10.2.4 Market Breakup by Drug Delivery
        10.2.5 Market Breakup by Distribution Channel
        10.2.6 Market Forecast
    10.3    Rwanda
        10.3.1 Market Trends
        10.3.2 Market Breakup by Segment
        10.3.3 Market Breakup by Therapy Area
        10.3.4 Market Breakup by Drug Delivery
        10.3.5 Market Breakup by Distribution Channel
        10.3.6 Market Forecast
    10.4    Kenya
        10.4.1 Market Trends
        10.4.2 Market Breakup by Segment
        10.4.3 Market Breakup by Therapy Area
        10.4.4 Market Breakup by Drug Delivery
        10.4.5 Market Breakup by Distribution Channel
        10.4.6 Market Forecast
    10.5    Tanzania
        10.5.1 Market Trends
        10.5.2 Market Breakup by Segment
        10.5.3 Market Breakup by Therapy Area
        10.5.4 Market Breakup by Drug Delivery
        10.5.5 Market Breakup by Distribution Channel
        10.5.6 Market Forecast
    10.6    Others
        10.6.1 Market Trends
        10.6.2 Market Breakup by Segment
        10.6.3 Market Breakup by Therapy Area
        10.6.4 Market Breakup by Drug Delivery
        10.6.5 Market Breakup by Distribution Channel
        10.6.6 Market Forecast
11  SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12  Value Chain Analysis
13  Porters Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14  Price Analysis
15  Policy and Regulatory Landscape
16  Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players

List of Figures

Figure 1: East Africa: Generic Drug Market: Major Drivers and Challenges
Figure 2: East Africa: Generic Drug Market: Sales Value (in Billion US$), 2016-2021
Figure 3: East Africa: Generic Drug Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: East Africa: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 5: East Africa: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 6: East Africa: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 7: East Africa: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 8: East Africa: Generic Drug Market: Breakup by Country (in %), 2021
Figure 9: East Africa: Generic Drug (Unbranded Generics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: East Africa: Generic Drug (Unbranded Generics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: East Africa: Generic Drug (Branded Generics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: East Africa: Generic Drug (Branded Generics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: East Africa: Generic Drug (Central Nervous System) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: East Africa: Generic Drug (Central Nervous System) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: East Africa: Generic Drug (Cardiovascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: East Africa: Generic Drug (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: East Africa: Generic Drug (Dermatology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: East Africa: Generic Drug (Dermatology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: East Africa: Generic Drug (Genitourinary/Hormonal) Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: East Africa: Generic Drug (Genitourinary/Hormonal) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: East Africa: Generic Drug (Respiratory) Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: East Africa: Generic Drug (Respiratory) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: East Africa: Generic Drug (Rheumatology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: East Africa: Generic Drug (Rheumatology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: East Africa: Generic Drug (Diabetes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: East Africa: Generic Drug (Diabetes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: East Africa: Generic Drug (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: East Africa: Generic Drug (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 29: East Africa: Generic Drug (Other Therapy Areas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 30: East Africa: Generic Drug (Other Therapy Areas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 31: East Africa: Generic Drug (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 32: East Africa: Generic Drug (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: East Africa: Generic Drug (Injectables) Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: East Africa: Generic Drug (Injectables) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 35: East Africa: Generic Drug (Dermal/Topical) Market: Sales Value (in Million US$), 2016 & 2021
Figure 36: East Africa: Generic Drug (Dermal/Topical) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 37: East Africa: Generic Drug (Inhalers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 38: East Africa: Generic Drug (Inhalers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: East Africa: Generic Drug (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: East Africa: Generic Drug (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 41: East Africa: Generic Drug (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 42: East Africa: Generic Drug (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 43: Uganda: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 44: Uganda: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 45: Uganda: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 46: Uganda: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 47: Uganda: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 48: Uganda: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 49: Burundi: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 50: Burundi: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 51: Burundi: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 52: Burundi: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 53: Burundi: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 54: Burundi: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 55: Rwanda: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 56: Rwanda: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 57: Rwanda: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 58: Rwanda: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 59: Rwanda: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 60: Rwanda: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 61: Kenya: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 62: Kenya: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 63: Kenya: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 64: Kenya: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 65: Kenya: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 66: Kenya: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 67: Tanzania: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 68: Tanzania: Generic Drug Market: Breakup by Segment (in %), 2021
Figure 69: Tanzania: Generic Drug Market: Breakup by Therapy Area (in %), 2021
Figure 70: Tanzania: Generic Drug Market: Breakup by Drug Delivery (in %), 2021
Figure 71: Tanzania: Generic Drug Market: Breakup by Distribution Channel (in %), 2021
Figure 72: Tanzania: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 73: Others: Generic Drug Market: Sales Value (in Million US$), 2016 & 2021
Figure 74: Others: Generic Drug Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 75: East Africa: Generic Drug Industry: SWOT Analysis
Figure 76: East Africa: Generic Drug Industry: Value Chain Analysis
Figure 77: East Africa: Generic Drug Industry: Porter’s Five Forces Analysis

List of Tables

Table 1: East Africa: Generic Drug Market: Key Industry Highlights, 2021 and 2027
Table 2: East Africa: Generic Drug Market Forecast: Breakup by Segment (in Million US$), 2022-2027
Table 3: East Africa: Generic Drug Market Forecast: Breakup by Therapy Area (in Million US$), 2022-2027
Table 4: East Africa: Generic Drug Market Forecast: Breakup by Drug Delivery (in Million US$), 2022-2027
Table 5: East Africa: Generic Drug Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 6: East Africa: Generic Drug Market Forecast: Breakup by Country (in Million US$), 2022-2027
Table 7: East Africa: Generic Drug Market: Key Players


Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2699

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links

4